Summary of successful treatment and manage experience of refractory Crohn′s disease anal fistula complicated with severe infection （1 case report）

doi:10.3969/j.issn.1009-976X.2024.03.009

Abstract

Abstract: Objective To introduce the successful treatment and management experience of a severe patient with perianal fistulizing Crohn's disease （pfCD） and perianal abscess. Methods The clinical data of a patient with pfCD complicated with perianal abscess admitted to the Gastroenterology Dept. of Sun Yat-sen Memorial Hospital of Sun Yat-sen University were retrospectively analyzed. Results The patient's condition was improved and discharged after 65 days of disease management. Conclusion pfCD with perianal abscess is clinically challenging to treat. The key to successful treatment lies in multidisciplinary team （MDT） combined treatment and individualized management measures.

Key words: Crohn's disease, anal fistula, perianal abscess, anal fistula irrigation

摘要： 目的总结1例克罗恩病肛瘘合并肛周脓肿的重症患者的治疗与护理经验。方法回顾性分析中山大学孙逸仙纪念医院消化内科收治1例克罗恩病肛瘘合并肛周脓肿患者的临床治疗资料。结果患者经内科治疗与护理65天后情况好转出院。结论克罗恩病合并肛瘘、肛周脓肿,临床治疗棘手,治疗成功的关键在于多学科联合治疗及个体化管理措施。

关键词: 克罗恩病, 肛瘘, 肛周脓肿, 肛瘘冲洗

CLC Number:

R657.1

RUAN Jian-Min, LI Yong-Jie, LIN Jie-mei, LIU Li. Summary of successful treatment and manage experience of refractory Crohn′s disease anal fistula complicated with severe infection （1 case report）[J]. Lingnan Modern Clinics In Surgery, 2024, 24(03): 199-205.

阮剑敏, 李永洁, 林洁梅, 刘莉. 难治性克罗恩病肛瘘合并严重感染的成功管理经验总结（1例报告）[J]. 岭南现代临床外科, 2024, 24(03): 199-205.

References

[1] 克罗恩病肛瘘共识专家组. 克罗恩病肛瘘诊断与治疗的专家共识意见[J]. 中华炎性肠病杂志(中英文),2019,3(2):105-110.
[2] Adegbola SO, Dibley L, Sahnan K, et al.Burden of disease and adaptation to life in patients with Crohn's perianal fistula: a qualitative exploration[J]. Health Qual Life Outcomes,2020, 18(1):370.
[3] 中华医学会消化病学分会炎症性肠病学组, 中华医学会肠外与肠内营养学分会胃肠病与营养协作组. 炎症性肠病营养支持治疗专家共识 (第二版)[J]. 中华炎性肠病杂志 (中英文), 2018, 2(3): 154-172.
[4] 李悠然, 吴旻娜, 颜蕾, 谷云飞. 确定性手术治愈的肛周瘘管型克罗恩病1例[J]. 中国临床案例成果数据库,2022,4(1): E01285-E01285.
[5] Kotfis K, Zegan-Barańska M, Szydłowski Ł, et al.Methods of pain assessment in adult intensive care unit patients-Polish version of the CPOT (Critical Care Pain Observation Tool) and BPS (Behavioral Pain Scale)[J]. Anaesthesiol Intensive Ther, 2017, 49(1): 66-72.
[6] Barberio B, Zamani M, Black CJ, et al.Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2021, 6(5): 359-370.
[7] Keefer L.What can we do to tackle anxiety and depression in patients with inflammatory bowel disease?[J]. Lancet Gastroenterol Hepatol, 2021, 6(5): 337-338.
[8] Siegel CA, Whitman CB, Spiegel BMR, et al.Development of an index to define overall disease severity in IBD[J]. Gut, 2018, 67(2): 244-254.
[9] Feuerstein JD, Ho EY, Shmidt E, et al.AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease[J]. Gastroenterology, 2021, 160(7): 2496-2508.
[10] 朱维铭. 难治性肛周克罗恩病处理面临的挑战[J]. 中华炎性肠病杂志(中英文), 2023, 7(3): 209-213.
[11] 姚潇, 高金波. 生物治疗联合外科治疗克罗恩病肛周病变的策略和进展[J]. 岭南现代临床外科, 2023, 23(4): 360-367.
[12] Lee MJ, Heywood N, Sagar PM, et al.Association of Coloproctology of Great Britain and Ireland consensus exercise on surgical management of fistulating perianal Crohn's disease[J]. Colorectal Dis, 2017, 19(5): 418-429.
[13] Gilliland A, Chan JJ, De Wolfe TJ, et al.Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care[J]. Gastroenterology, 2024, 166(1): 44-58.
[14] Zhao W, Yang H, Huang Y, et al.Genomic Sequencing of Clinical Cupriavidus gilardii Isolates Revealed Their Diverse Antimicrobial Resistance Mechanisms[J]. Infect Drug Resist, 2024, 17: 655-664.
[15] Kweon OJ, Lim YK, Kim HR, et al.Isolation of a novel species in the genus Cupriavidus from a patient with sepsis using whole genome sequencing[J]. PLoS One, 2020, 15(5): e0232850.
[16] Zhou Y, Chen H, He H, et al.Increased Enterococcus faecalis infection is associated with clinically active Crohn disease[J]. Medicine (Baltimore), 2016, 95(39): e5019.
[17] Beganovic M, Luther MK, Rice LB, et al.A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis[J]. Clin Infect Dis, 2018, 67(2): 303-309.
[18] Economou M, Pappas G.New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations[J]. Inflamm Bowel Dis, 2008, 14(5): 709-720.
[19] Kaur CP, Vadivelu J, Chandramathi S.Impact of Klebsiella pneumoniae in lower gastrointestinal tract diseases[J]. J Dig Dis, 2018, 19(5): 262-271.
[20] Kamada M, Miyazaki M, Nakashima A, et al.Characteristics of Patients With Inflammatory Bowel Disease Who Develop Bloodstream Infection[J]. J Clin Med Res, 2023, 15(5): 262-267.
[21] Mylonaki M, Langmead L, Pantes A, et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool[J]. Eur J Gastroenterol Hepatol, 2004, 16(8): 775-778.
[22] Biancone L, Annese V, Ardizzone S, et al.Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)[J]. Dig Liver Dis, 2017, 49(4): 338-358.
[23] Ardizzone S, Armuzzi A, Caprioli F, et al.Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus[J]. Dig Liver Dis, 2024, 56(1): 98-105.
[24] Targownik LE, Bernstein CN, Benchimol EI, et al. Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn's Disease but Not in Ulcerative Colitis[J]. Clin Gastroenterol Hepatol, 2022, 20(11): 2607-2618.e14.
[25] 中华医学会消化病学分会炎症性肠病学组, 中国炎症性肠病诊疗质量控制评估中心.中国克罗恩病诊治指南(2023年·广州)[J]. 中华炎性肠病杂志(中英文), 2024, 8(1): 2-32.